ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
Go back to ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.26 | 52 Week High | $63.73 | |||
| Open | $17.26 | 52 Week Low | $8.00 | |||
| Day High | $17.26 | P/E | N/A | |||
| Day Low | $17.26 | EPS | $-5.69 | |||
| Volume | 813 | |||||

